GLP-1 Comparison Illustration
Directional scenario modeling for GLP-1 receptor agonists
48F Recalibration
Age: 48
Sex: female
Weight: 80kg
Body Fat: 63%
Scenario Controls
SEMAGLUTIDE
TIRZEPATIDE
RETATRUTIDE
Fat Mass Change (scaled %)
Lean Mass Change (scaled %)
Important: These trajectories are directional comparisons. They illustrate how compound, dose, exercise, and protein intake shift fat and lean trends over time. Not medical advice or precise predictions.